References
- Kino T, Hatanaka H, Hashimoto M, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot. 1987;40:1249–1255.
- Haddad EM, McAlister VC, Renouf E, et al. Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev. 2006;CD005161.
- Penninga L, Penninga EI, Møller CH, et al. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Cochrane Database Syst Rev. 2013;31:CD008817.
- Webster A, Woodroffe RC, Taylor RS, et al. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev. 2005;19:CD003961.
- Rath T. Tacrolimus in transplant rejection. Expert Opin Pharmacother. 2013;14:115–122.
- Kino T, Hatanaka H, Miyata S, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot. 1987;40:1256–1265.
- Ponticelli C. Present and future of immunosuppressive therapy in kidney transplantation. Transplant Proc. 2011;43:2439–2440.
- Iwasaki K. Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics. Drug Metab Pharmacokinet. 2007;22:328–335.
- Rodriguez-Perálvarez M, Germani G, Darius T, et al. Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis. Am J Transplant. 2012;12:2797–2814.
- Rodriguez- Perálvarez M, Germani G, Darius T, et al. Reducing early exposure to calcineurin inhibitors: the key factor for a successful renal sparing strategy. Am J Transplant. 2013;13:239.
- Bazin C, Guinedor A, Barau C, et al. Evaluation of the architect tacrolimus assay in kidney, liver, and heart transplant recipients. J Pharm Biomed Anal. 2010;53:997–1002.
- Hashi S, Masuda S, Kikuchi M, et al. Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients. Transplant Proc. 2014;46:758–760.
- Joo DJ, Jung I, Kim MS, et al. Comparison of the affinity column-mediated immunoassay and microparticle enzyme immunoassay methods as a tacrolimus concentration assay in the early period after liver transplantation. Transplant Proc. 2010;42:4137–4140.
- Ju MK, Chang HK, Kim HJ, et al. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay? Transplant Proc. 2008;40:3673–3678.
- Warty V, Zuckerman S, Venkataramanan R, et al. Tacrolimus analysis. A comparison of different methods and matrices. Ther Drug Monit. 1995;17:159–167.
- Ko DH, Jeong TD, Lee W, et al. Performance evaluation of a restored dimension TACR assay: an automated platform for measuring the whole blood tacrolimus concentration. Clin Lab. 2016;62:7–12.
- Vogeser M, Shipkova M, Rigo-Bonnin R, et al. Multicenter analytical evaluation of the automated electrochemiluminescence immunoassay for cyclosporine. Ther Drug Monit. 2014;36:640–650.
- Shipkova M, Vogeser M, Ramos PA, et al. Multi-center analytical evaluation of a novel automated tacrolimus immunoassay. Clin Biochem. 2014;47:1069–1077.
- Chung JW, An D, Song J, et al. Performance evaluation of affinity column mediated immunometric assay for tacrolimus. Korean J Lab Med. 2009;29:415–422.
- Wallemacq P, Goffinet JS, O'Morchoe S, et al. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay. Ther Drug Monit. 2009;31:198–204.
- Wallemacq P, Maine GT, Berg K, et al. Multisite analytical evaluation of the Abbott ARCHITECT cyclosporine assay. Ther Drug Monit. 2010;32:145–151.
- Wallemacq P, Armstrong VW, Brunet M, et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit. 2009;31:139–152.
- Ventura E, Bonardet A, Pageaux GP, et al. Calcineurin inhibitor determination in whole blood with the RXL dimension analyzer: a useful tool for immunosuppressive drug monitoring. Transplant Proc. 2009;41:707–709.
- Steimer W. Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific? Clin Chem. 1999;45:371–381.
- College of American Pathologists. Immunosuppressive drugs participant summary report, CSM-B surveys: CAP; 2016.